CancerFree Biotech
透過血液檢體,幫助癌症患者在體外打造個人化腫瘤分身,代替患者進行抗癌藥物測試(包含化療藥物、荷爾蒙藥物及標靶藥物),提供最直接的藥物效用評估,達到個人化精準治療,降低無效用藥的可能性。
Signals
X account@CancerFreeBio · created May 29, 2019 (7 years old) · 53 followers
Website registeredFeb 12, 2019 (7 years old)
Timeline
- X account created
- Website created
- Batch 12
BBerkeley SkyDeck · batch
Source: skydeck.berkeley.edu
Investors
Similar Health and bio companies
DDuet$15M Series A · Nov 2026
SSkribe Medical$1.65M Pre Seed · Nov 2026
EEli Radiopharma$59.96M Series A · Nov 2026SSE3 Labs$30M Seed · Nov 2026
SSleep.ai$5.3M · Nov 2026
EEnVision Endoscopy$11.5M Series A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cancerfree-biotech-ltd (get a free API key).